Literatur
Fox K, Ford I, Steg PG et al. (2008) On behalf of the BEAUTIFUL investigators. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372: 807–816
Tardif JC, Ford I, Tendera M et al. (2005) Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J 26: 2529–2536
Wilhelmsen I, Berglund G, Elmfeldt D et al. (1986) The multifactor primary prevention trial in Goteborg, Sweden. Eur Heart J 7: 279–288
Palatini P, Casiglia E, Pauletto P (1994) Relation between physical training and ambulatory blood pressure in stage I hypertensive subjects: results of the HARVEST trial. Circulation 90: 2870–2872
Diaz A, Bourassa GM, Guertin MC, Tardif JC (2005) Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 26: 967–974
Interessenkonflikt
Keine Angaben.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Graf, K. Die BEAUTIFUL-Studie. Kardiologe 2, 488–490 (2008). https://doi.org/10.1007/s12181-008-0130-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12181-008-0130-9